Coastal Infusion Administers Reclast™
| J-Code | J3489 |
|---|---|
| Manufacturer | Novartis |
| First Approved | 08/20/2007 |
Coastal Infusion can administer your Reclast prescription at any of our south Florida locations.
Reclast (zoledronic acid) is used to treat osteoporosis in postmenopausal women at elevated risk of fractures. Osteoporosis is a condition characterized by low bone mass and poor bone structure, which makes bones fragile and more prone to fractures. By impeding bone resorption, Reclast contributes to the preservation or augmentation of bone mineral density, offering improved structural support and a decreased likelihood of fractures.
Beyond its use in osteoporosis management, Reclast is utilized for the treatment of Paget’s disease of the bone, a condition characterized by abnormal bone remodeling. Reclast plays a crucial role in regulating bone turnover, fostering healthier bone structure, and addressing the specific challenges associated with Paget’s disease.
What It Treats
- Osteoporosis
- Paget’s Disease
Prescribed By
Reclast is most often prescribed by Neurologists.
How it’s Administered
Reclast is administered by intravenous infusion. Reclast infusions take only a few minutes.
Frequency
Reclast is generally administered once every two years.
Related Drugs
Additional Resources
The information on this page is compiled from a variety of online sources. Coastal Infusion has made every effort to verify its accuracy, but patients are advised to discuss any planned or current treatments with their doctor. Report inaccuracies